The new SpectraMax iD5 multi-mode microplate reader from Molecular Devices is a hybrid five-mode microplate reader that features automatic near-field communication (NFC) filter identification and western blot capability. Expanding on the feature set of the SpectraMax iD3, which was released in early 2017, the new product is a complete solution to help scientists increase their research capabilities.
The SpectraMax iD5 comes with built-in absorbance, fluorescence, luminescence, time-resolved fluorescence (TRF), and tunable fluorescence polarisation (FP) read modes. In addition, it can be expanded to include bottom-read luminescence, TR-FRET, HTRF, BRET, dual luciferase reporter assays with injectors, and western blot detection. With optimised reagents and the data acquisition and analysis tool, SoftMax Pro 7 software, the new reader is an ‘all-access pass’ to the next big breakthrough in scientific research.
“This complete solution with built-in NFC tags, ability to capture flash assays with ease, onboard user access control for multi-user labs, and intuitive touchscreen interface, enables our customers to easily increase productivity,” says Greg Milosevich, president of Molecular Devices. “In addition, our SoftMax Pro GxP Compliance Software extends our data acquisition and analysis solution into regulated laboratories working under GMP, GLP, 21 CFR Part 11, and other similar guidelines for secure electronic records.”
Key features include:
Use NFC tags to login to a personalised touchscreen homepage to easily run experiments or view results
Automatically identify filter sets using NFC functionality, simplifying workflows and eliminating confusion
Perform western blot detection with the microplate reader
Push data to workstations using QuickSync, eliminating the need to retrieve data from the instrument
Detect assay signal using the superior hybrid monochromator- and filter-based optical system
Run injector assays with SmartInject technology, ensuring complete reagent mixing and rapid signal development
A new application note on monitoring NF-KB activation with sensitive dual reporter assays can be downloaded from the company’s website. It shows how to detect multiplexed luciferase assay results with a sensitive dual reporter assay and improve the accuracy of results by normalising reporter expression to a control. This application was enabled using the new SpectraMax iD5.
Celeste Glazer is with Molecular Devices.